Moreover, S1PR2 expressed in host endothelial cells and tumor-infiltrating myeloid cells in concert mediates the inhibition of tumor angiogenesis through the inhibition of vascular endothelial growth factor expression and matrix metalloproteinase 9 activity [45]. This evidence concerns the gene S1PR2 and neoplasm.